Literature DB >> 11463786

The cleavage of Akt/protein kinase B by death receptor signaling is an important event in detachment-induced apoptosis.

R E Bachelder1, M A Wendt, N Fujita, T Tsuruo, A M Mercurio.   

Abstract

Epithelial cells undergo death receptor-dependent apoptosis when detached from matrix, a process termed anoikis. Activation of Akt/protein kinase B (PKB) by matrix attachment protects cells from anoikis. In this study, we establish a link between anoikis and Akt/PKB-mediated survival by demonstrating that Akt/PKB is cleaved by caspases in matrix-detached epithelial cells by a mechanism that involves death receptors. Reduced levels of Akt/PKB protein were observed in detached Madin-Darby canine kidney cells relative to cells attached to collagen. Equivalent levels of Akt/PKB, however, were detected in matrix-adherent and detached cells after inhibition of caspase activity or expression of an Akt/PKB mutant (D108+119A) that is resistant to caspase cleavage. The contribution of death domain-containing proteins to Akt/PKB cleavage was evidenced by the ability of dominant negative Fas-associated death domain to restore normal levels of Akt/PKB in matrix-detached cells. Importantly, expression of a cleavage-resistant Akt/PKB mutant protected matrix-detached cells from apoptosis. These studies suggest that members of the death receptor family promote the caspase-mediated cleavage of Akt/PKB and that this event contributes to anoikis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463786     DOI: 10.1074/jbc.M102806200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Evidence for an Akt-kinase/NO/cGMP pathway in the cochlea of guinea pigs.

Authors:  Alexander Hess; Daniel Labbé; Ken-Ichi Watanabe; Wilhelm Bloch; Olaf Michel
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-09       Impact factor: 2.503

Review 2.  Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li
Journal:  Curr Neurovasc Res       Date:  2005-12       Impact factor: 1.990

Review 3.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

4.  TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation.

Authors:  V K Puduvalli; D Sampath; J M Bruner; J Nangia; R Xu; A P Kyritsis
Journal:  Apoptosis       Date:  2005-01       Impact factor: 4.677

5.  Increased cell survival, migration, invasion, and Akt expression in PTHrP-overexpressing LoVo colon cancer cell lines.

Authors:  Xiaoli Shen; Ramanjaneya V R Mula; B Mark Evers; Miriam Falzon
Journal:  Regul Pept       Date:  2007-01-10

6.  Physiological regulation of Akt activity and stability.

Authors:  Yong Liao; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2010-01-01       Impact factor: 4.060

Review 7.  Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies.

Authors:  Brigitte Onténiente; Sowmyalakshmí Rasika; Alexandra Benchoua; Christelle Guégan
Journal:  Mol Neurobiol       Date:  2003-02       Impact factor: 5.590

8.  Degradation and dephosphorylation of focal adhesion kinase during okadaic acid-induced apoptosis in human neuroblastoma cells.

Authors:  Bhumsoo Kim; Cynthia M van Golen; Eva L Feldman
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

9.  Anti-apoptotic role of caspase-cleaved GAB1 adaptor protein in hepatocyte growth factor/scatter factor-MET receptor protein signaling.

Authors:  Arnaud Le Goff; Zongling Ji; Bérénice Leclercq; Roland P Bourette; Alexandra Mougel; Cateline Guerardel; Yvan de Launoit; Jérôme Vicogne; Gautier Goormachtigh; Véronique Fafeur
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

Review 10.  Caspases and kinases in a death grip.

Authors:  Manabu Kurokawa; Sally Kornbluth
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.